These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 34384016)
21. Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan. Nomura H; Abe A; Fusegi A; Yoshimitsu T; Misaka S; Murakami A; Matsumoto T; Tsumura S; Kanno M; Aoki Y; Netsu S; Omi M; Tanigawa T; Okamoto S; Omatsu K; Yunokawa M; Kanao H; Habano E; Arakawa H; Kaneko K; Ueki A; Haruyama Y; Inari H; Ueno T Sci Rep; 2023 Jan; 13(1):1018. PubMed ID: 36658289 [TBL] [Abstract][Full Text] [Related]
22. Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study. Grandi G; Sammarini M; Cortesi L; Toss A; Botticelli L; Varliero F; Sighinolfi G; Barbieri E; Facchinetti F Menopause; 2021 Feb; 28(3):263-270. PubMed ID: 33534430 [TBL] [Abstract][Full Text] [Related]
23. Factors associated with intentions for breast cancer risk management: Does risk group matter? Conley CC; Agnese DM; Vadaparampil ST; Andersen BL Psychooncology; 2019 May; 28(5):1119-1126. PubMed ID: 30889627 [TBL] [Abstract][Full Text] [Related]
24. Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy? Grandi G; Perrone AM; Perrone A; Mandato VD; Comerci G; Sammarini M; Merisio C; Amadori A; Stefanetti M; Martinello R; Facchinetti F; De Iaco P; Maturitas; 2021 Jan; 143():59-64. PubMed ID: 33308637 [TBL] [Abstract][Full Text] [Related]
25. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know. Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561 [TBL] [Abstract][Full Text] [Related]
26. Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations. Julian-Reynier C; Mancini J; Mouret-Fourme E; Gauthier-Villars M; Bonadona V; Berthet P; Fricker JP; Caron O; Luporsi E; Noguès C Eur J Hum Genet; 2011 May; 19(5):500-6. PubMed ID: 21267012 [TBL] [Abstract][Full Text] [Related]
27. Comparing Coordinated Versus Sequential Salpingo-Oophorectomy for BRCA1 and BRCA2 Mutation Carriers With Breast Cancer. S Chapman J; Roddy E; Panighetti A; Hwang S; Crawford B; Powell B; Chen LM Clin Breast Cancer; 2016 Dec; 16(6):494-499. PubMed ID: 27495996 [TBL] [Abstract][Full Text] [Related]
28. Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers: A Nonrandomized Controlled Trial. Steenbeek MP; Harmsen MG; Hoogerbrugge N; de Jong MA; Maas AHEM; Prins JB; Bulten J; Teerenstra S; van Bommel MHD; van Doorn HC; Mourits MJE; van Beurden M; Zweemer RP; Gaarenstroom KN; Slangen BFM; Brood-van Zanten MMA; Vos MC; Piek JMJ; van Lonkhuijzen LRCW; Apperloo MJA; Coppus SFPJ; Massuger LFAG; IntHout J; Hermens RPMG; de Hullu JA JAMA Oncol; 2021 Aug; 7(8):1203-1212. PubMed ID: 34081085 [TBL] [Abstract][Full Text] [Related]
29. The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy. van der Aa JE; Hoogendam JP; Butter ES; Ausems MG; Verheijen RH; Zweemer RP Fam Cancer; 2015 Dec; 14(4):539-44. PubMed ID: 26264902 [TBL] [Abstract][Full Text] [Related]
30. Uptake Rate of Risk-Reducing Salpingo-Oophorectomy and Surgical Outcomes of Female Germline Lim H; Kim SI; Hyun S; Lee GB; Seol A; Lee M Yonsei Med J; 2021 Dec; 62(12):1090-1097. PubMed ID: 34816639 [TBL] [Abstract][Full Text] [Related]
31. A Psychological Perspective on Factors Predicting Prophylactic Salpingo-Oophorectomy in a Sample of Italian Women from the General Population. Results from a Hypothetical Study in the Context of BRCA Mutations. Gavaruzzi T; Tasso A; Franiuk M; Varesco L; Lotto L J Genet Couns; 2017 Oct; 26(5):1144-1152. PubMed ID: 28337671 [TBL] [Abstract][Full Text] [Related]
32. Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers. Singh K; Lester J; Karlan B; Bresee C; Geva T; Gordon O Am J Obstet Gynecol; 2013 Apr; 208(4):329.e1-6. PubMed ID: 23333547 [TBL] [Abstract][Full Text] [Related]
33. Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers. Perabò M; Fink V; Günthner-Biller M; von Bodungen V; Friese K; Dian D Arch Gynecol Obstet; 2014 Jun; 289(6):1325-30. PubMed ID: 24389920 [TBL] [Abstract][Full Text] [Related]
34. Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia. Ložar T; Žgajnar J; Perhavec A; Blatnik A; Novaković S; Krajc M Eur J Surg Oncol; 2021 Aug; 47(8):1900-1906. PubMed ID: 33812767 [TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer. Heiniger L; Butow PN; Coll J; Bullen T; Wilson J; Baylock B; Meiser B; Price MA Fam Cancer; 2015 Mar; 14(1):105-15. PubMed ID: 25283514 [TBL] [Abstract][Full Text] [Related]
36. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. Kauff ND; Satagopan JM; Robson ME; Scheuer L; Hensley M; Hudis CA; Ellis NA; Boyd J; Borgen PI; Barakat RR; Norton L; Castiel M; Nafa K; Offit K N Engl J Med; 2002 May; 346(21):1609-15. PubMed ID: 12023992 [TBL] [Abstract][Full Text] [Related]